Terry Katz

826 total citations
31 papers, 659 citations indexed

About

Terry Katz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Terry Katz has authored 31 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Terry Katz's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Terry Katz is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Terry Katz collaborates with scholars based in United States, Israel and Vietnam. Terry Katz's co-authors include P. Lockwood, R. G. Endris, Hagop Youssoufian, Floyd E. Fox, Eric K. Rowinsky, Celestia S. Higano, Robert D. Armstrong, Samuel H. Whiting, Patricia LoRusso and Michael Gordon and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and The Lancet Oncology.

In The Last Decade

Terry Katz

31 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terry Katz United States 15 211 176 151 110 83 31 659
Bryan W Neville United States 14 224 1.1× 376 2.1× 134 0.9× 86 0.8× 140 1.7× 66 1.5k
Alan M. Seddon United Kingdom 19 239 1.1× 242 1.4× 121 0.8× 98 0.9× 76 0.9× 40 783
Gregory B. Pott United States 13 141 0.7× 221 1.3× 245 1.6× 238 2.2× 151 1.8× 24 1.0k
Kyoko Sakai Japan 18 97 0.5× 267 1.5× 148 1.0× 379 3.4× 35 0.4× 44 1.4k
Keiko Kawaguchi Japan 12 174 0.8× 542 3.1× 78 0.5× 227 2.1× 86 1.0× 28 1.7k
D Michaeli United States 16 147 0.7× 287 1.6× 80 0.5× 154 1.4× 27 0.3× 66 957
Danila Seidel Germany 22 318 1.5× 271 1.5× 380 2.5× 48 0.4× 179 2.2× 50 1.8k
Lena J. Heung United States 11 151 0.7× 330 1.9× 42 0.3× 167 1.5× 181 2.2× 18 1.0k
Inês Pinto-Ribeiro Portugal 10 118 0.6× 481 2.7× 206 1.4× 124 1.1× 52 0.6× 14 916
I Taylor United States 13 336 1.6× 575 3.3× 110 0.7× 12 0.1× 67 0.8× 34 952

Countries citing papers authored by Terry Katz

Since Specialization
Citations

This map shows the geographic impact of Terry Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Katz more than expected).

Fields of papers citing papers by Terry Katz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Katz. The network helps show where Terry Katz may publish in the future.

Co-authorship network of co-authors of Terry Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Katz. A scholar is included among the top collaborators of Terry Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Katz. Terry Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katz, Terry, et al.. (2020). Toolkit for ICH E6 (R2) Quality Risk Management for Small to Medium Size Companies. Therapeutic Innovation & Regulatory Science. 54(4). 900–921. 2 indexed citations
2.
Katz, Terry, et al.. (2016). PO-45 - The role of microvesicles in multiple myeloma progression. Thrombosis Research. 140. S193–S193. 8 indexed citations
3.
Mehra, Mandeep R., et al.. (2016). A Toolkit for the Management of Protocol Deviations. Therapeutic Innovation & Regulatory Science. 50(6). 791–800. 7 indexed citations
4.
Mehra, Mandeep R., et al.. (2014). The Life Cycle and Management of Protocol Deviations. Therapeutic Innovation & Regulatory Science. 48(6). 762–777. 19 indexed citations
5.
Kim, Edward S., Marcus A. Neubauer, Allen Lee Cohn, et al.. (2013). Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial. The Lancet Oncology. 14(13). 1326–1336. 50 indexed citations
6.
Bonomi, Philip, Joseph R. Mace, Romeo A. Mandanas, et al.. (2013). Randomized Phase II Study of Cetuximab and Bevacizumab in Combination with Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(3). 338–345. 14 indexed citations
7.
Kim, Edward S., Marcus A. Neubauer, Allen Lee Cohn, et al.. (2012). SELECT: Randomized phase III study of docetaxel (D) or pemetrexed (P) with or without cetuximab (C) in recurrent or progressive non-small cell lung cancer (NSCLC) after platinum-based therapy.. Journal of Clinical Oncology. 30(15_suppl). 7502–7502. 3 indexed citations
8.
Ko, Andrew H., Hagop Youssoufian, Jayne Gurtler, et al.. (2011). A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma. Investigational New Drugs. 30(4). 1597–1606. 49 indexed citations
9.
10.
Wierzbicki, Rafal, Derek J. Jonker, Malcolm J. Moore, et al.. (2008). A phase II multicenter study of cetuximab monotherapy in patients with EGFR-undetectable refractory metastatic colorectal carcinoma (mCRC). Journal of Clinical Oncology. 26(15_suppl). 4065–4065. 5 indexed citations
11.
Youssoufian, Hagop, R. J. Amato, E. Gabriela Chiorean, et al.. (2008). Phase 1 study of IMC-3G3, an IgG1 monoclonal antibody targeting PDGFRα in patients with advanced solid malignancies. Journal of Clinical Oncology. 26(15_suppl). 14617–14617. 7 indexed citations
12.
LoRusso, Patricia, Michael A. Gordon, Evan Y. Yu, et al.. (2007). A phase I study of the recombinant human IgG1 anti-IGF-IR monoclonal antibody (Mab) IMC-A12, administered on a weekly basis to patients with advanced solid tumors: Interim analysis. Molecular Cancer Therapeutics. 6. 9 indexed citations
13.
Camidge, D. Ross, S. Gail Eckhardt, Sami Diab, et al.. (2006). A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer. Journal of Clinical Oncology. 24(18_suppl). 3032–3032. 25 indexed citations
14.
Lockwood, P., et al.. (2003). Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease. Veterinary Record. 152(13). 392–394. 66 indexed citations
15.
Wislocki, Peter G., et al.. (2003). Residue Depletion Study and Withdrawal Period for Flunixin-N-methyl Glucamine in Bovine Milk Following Intravenous Administration. Journal of Agricultural and Food Chemistry. 51(16). 4701–4707. 11 indexed citations
16.
Endris, R. G., et al.. (2002). Efficacy of two 65 % permethrin spot-on formulations against canine infestations of Ctenocephalides felis and Rhipicephalus sanguineus.. PubMed. 3(3). 326–33. 6 indexed citations
17.
Elhasid, Ronit, et al.. (2000). Successful haploidentical bone marrow transplantation in Fanconi anemia. Bone Marrow Transplantation. 26(11). 1221–1223. 13 indexed citations
18.
MacKay, Robert J., James E. Bailey, Karen Gillis, et al.. (2000). Effect of eltenac in horses with induced endotoxaemia. Equine Veterinary Journal. 32(S32). 26–31. 12 indexed citations
19.
Armstrong, Robert D., et al.. (2000). A field efficacy evaluation of emamectin benzoate for the control of sea lice on Atlantic salmon.. PubMed. 41(8). 607–12. 45 indexed citations
20.
HAMM, D., et al.. (1997). Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis. American Journal of Veterinary Research. 58(3). 298–302. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan W Neville Breakdown of academic impact, for papers by Alan M. Seddon Breakdown of academic impact, for papers by Gregory B. Pott Breakdown of academic impact, for papers by Kyoko Sakai Breakdown of academic impact, for papers by Keiko Kawaguchi Breakdown of academic impact, for papers by D Michaeli Breakdown of academic impact, for papers by Danila Seidel Breakdown of academic impact, for papers by Lena J. Heung Breakdown of academic impact, for papers by Inês Pinto-Ribeiro Breakdown of academic impact, for papers by I Taylor
Rankless by CCL
2026